Nanosciences and nanotechnology for medical applications

Fidia strengthens its presence in the North American market.

9/6/2005  - Company news

Fidia Farmaceutici SpA and Akorn, Inc. sign Letter of Intent to develop four ANDA drug products for commercialization.

Fidia strengthens its presence in the North American market.

13/10/2005  - Company news

Fidia Statement on Avian Flu and Hyalgan.

HYALGAN® (sodium hyaluronate) is effective in treating chronic shoulder pain due to osteoarthritis

Results of study presented at the 2005 American College of Rheumatology Annual Meeting in San Diego

16/11/2005  - Company news

Fidia Advanced Biopolymers and TiGenix enter into strategic partnership

Development and commercialization of novel biological implants for the repair of damaged and osteoarthritic joints

25/1/2007  - Company news

Fidia Advanced Biopolymers and the Nordic Group enter into strategic partnership

Commercialization of Hyalobarrier® gel in Europe

18/3/2008  - Company news

APR Applied Pharma Research and Fidia Farmaceutici Receive IND Approval from FDA for a New NSAID Matrix Patch Product

The U.S. FDA has accepted the IND application for the development of a 140mg Diclofenac Sodium Matrix Patch for the topical treatment of acute pain

17/11/2008  - Company news

Genzyme's European patent on cross-linked gel slurries has been entirely revoked by the EPO board of appeal.

Genzyme's EP patent has been finally revoked in its entirety by the EPO Board of Appeal

18/11/2008  - Company news